169 related articles for article (PubMed ID: 10190084)
1. Macrophage stimulation and antitumor effect of Ukrain.
Korolenko TA; Svechnikova IG; Filjushina EE; Kaledin VI; Vakulin GM; Usynin IF; Tsyrendordjiev DD
Drugs Exp Clin Res; 1998; 24(5-6):253-60. PubMed ID: 10190084
[TBL] [Abstract][Full Text] [Related]
2. The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy.
Svechnikova IG; Korolenko TA; Stashko JuF ; Kaledin VI; Nikolin VP; Nowicky JW
Drugs Exp Clin Res; 1998; 24(5-6):261-9. PubMed ID: 10190085
[TBL] [Abstract][Full Text] [Related]
3. Study of the antitumor effect of Ukrain: the role of macrophage secretion of alpha-1-proteinase inhibitor.
Korolenko TA; Kaledin VI; Svechnikova IG; Li XV; Stashko JF; Ilnitskaya SI; Nikolin VP
Drugs Exp Clin Res; 1998; 24(5-6):271-6. PubMed ID: 10190086
[TBL] [Abstract][Full Text] [Related]
4. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
5. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
[TBL] [Abstract][Full Text] [Related]
6. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
[TBL] [Abstract][Full Text] [Related]
7. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain.
Korolenko TA; Djanayeva SJ; Falameyeva OV; Wevers RA; Filjushina EE; Buzueva II; Kaledin VI; Sandula J; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):279-83. PubMed ID: 11345039
[TBL] [Abstract][Full Text] [Related]
8. Action of Ukrain, a cytostatic and immunomodulating drug, on effects of irradiation.
Boyko VN; Voltchek IV; Petrov AS; Bubnov VP
Drugs Exp Clin Res; 1996; 22(3-5):167-71. PubMed ID: 8899323
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
Sotomayor EM; Rao K; Lopez DM; Liepins A
Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
[TBL] [Abstract][Full Text] [Related]
11. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice.
Grinevich Y; Shalimov S; Bendyuh G; Zahriychuk O; Hodysh Y
Drugs Exp Clin Res; 2005; 31(2):59-70. PubMed ID: 15929607
[TBL] [Abstract][Full Text] [Related]
12. Six-week treatment with Ukrain in rabbits. Part III: Serum levels of thyroid hormones.
Jagiello-Wójtowicz E; Kleinrok Z; Feldo M; Chodkowska A; Szklarczyk V; Urbanska EM
Drugs Exp Clin Res; 1998; 24(5-6):305-8. PubMed ID: 10190092
[TBL] [Abstract][Full Text] [Related]
13. [Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy].
Poteriaeva ON; Korolenko TA; Svechnikova IG; Zhanaeva SIa; Falameeva OV; Kaledin VI; Nowicky JW
Biomed Khim; 2004; 50(2):172-9. PubMed ID: 15179824
[TBL] [Abstract][Full Text] [Related]
14. Interaction between Ukrain and Naltrexone in the writhing syndrome test in mice.
Jagiello-Wójtowicz E; Kleinrok Z; Gustaw K
Drugs Exp Clin Res; 1998; 24(5-6):327-30. PubMed ID: 10190097
[TBL] [Abstract][Full Text] [Related]
15. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
[TBL] [Abstract][Full Text] [Related]
16. The influence of the novel drug Ukrain on hemo- and immunopoiesis at the time of its maximum radioprotective effect.
Boyko VN; Belskiy SN
Drugs Exp Clin Res; 1998; 24(5-6):335-7. PubMed ID: 10190099
[TBL] [Abstract][Full Text] [Related]
17. Modification of antinociceptive action of Ukrain by endogenous nitric oxide in the writhing syndrome test in mice.
Jagiello-Wójtowicz E; Kleinrok Z; Chodkowska A; Szkodziak A; Siembida E; Gustaw K; Urbanska E
Drugs Exp Clin Res; 1998; 24(5-6):321-5. PubMed ID: 10190096
[TBL] [Abstract][Full Text] [Related]
18. The effect of NSC-631570 (ukrain) alone and in combination with pathogen-associated molecules on cell cycle distribution and apoptosis induction of mouse melanoma cells with different biological properties.
Skivka LM; Trompak OO; Kudryavets YI; Bezdenezhnykh NA; Susak YM
Exp Oncol; 2010 Jul; 32(2):92-6. PubMed ID: 20693969
[TBL] [Abstract][Full Text] [Related]
19. Ukrain (NSC-631570) in experimental and clinical studies: a review.
Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
[TBL] [Abstract][Full Text] [Related]
20. The influence of glucose, succinate, pH of the medium and higher temperature on the cytotoxic activity of the preparation Ukrain.
Todor IN; Kazmin SD; Susak YaM ; Zemskov SV
Drugs Exp Clin Res; 1998; 24(5-6):247-52. PubMed ID: 10190083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]